Skip to main content
· 2/20/2014

Takeda Pharmaceutical Co. v. Zydus Pharmaceuticals USA, Inc.

Citations

  • 743 F.3d 1359
  • 109 U.S.P.Q. 2d (BNA) 1825
  • 2014 U.S. App. LEXIS 3072
  • 2014 WL 642714

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • holding that a patent was adequately enabled “because the patent identifies laser diffraction as a viable measurement technique, and there is no dispute that a skilled artisan would know how to use laser diffraction to measure particle diameter”
  • concluding term “fine granules having an average particle diameter of 400 μm or less” meant “fine granules having an average particle diameter of precisely 400 μm or less”
  • explaining that the “mere possibility of different results” is insufficient for indefiniteness
  • explaining that the “mere possibility of different results” is insufficient for indefiniteness
  • explaining that the “mere possibility of different results” is insufficient for indefiniteness
  • refusing to read in a limitation because the specification indicated that the inventor knew how to claim such a limitation “when [he] so desired”

Source: CourtListener parenthetical corpus (CC0).

Judges: Prost, Plager, Chen

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.